Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biocidin REMOVE for SIBO in IBS
NCT07768267Phase 2Enrolling by invitation
- Sponsor
- Johns Hopkins University
- Start
- Oct 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Biocidin in small intestinal bacterial overgrowth (SIBO), sponsored by Johns Hopkins University. Started Oct 2026; status: enrolling by invitation.
02
Drugs
Biocidin
03
Conditions
small intestinal bacterial overgrowth (SIBO)
Beyond the preview
Go deeper on NCT07768267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07768267.